{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:50:21Z","timestamp":1790610621441,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801669"],"award-info":[{"award-number":["81801669"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271978"],"award-info":[{"award-number":["82271978"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2020717"],"award-info":[{"award-number":["BE2020717"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-023-04143-1","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T18:01:32Z","timestamp":1704909692000},"page":"471-483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta\u2011analysis"],"prefix":"10.1007","volume":"49","author":[{"given":"Shuwei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noble Chibuike","family":"Opara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghong","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6253-8311","authenticated-orcid":false,"given":"Yuan-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"key":"4143_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology (Baltimore, Md). 2018;67:358-80. https:\/\/doi.org\/10.1002\/hep.29086","journal-title":"Hepatology (Baltimore, Md)."},{"key":"4143_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"EASL Clinical Practice Guidelines","year":"2018","unstructured":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of hepatology. 2018;69:182-236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019","journal-title":"Journal of hepatology."},{"key":"4143_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","volume":"18","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T, Lencioni R. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nature reviews Gastroenterology & hepatology. 2021;18:293-313. https:\/\/doi.org\/10.1038\/s41575-020-00395-0","journal-title":"Nature reviews Gastroenterology & hepatology."},{"key":"4143_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik L, El-Serag HB. Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology. 2019;156:477-91.e1. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.065","journal-title":"Gastroenterology."},{"key":"4143_CR5","doi-asserted-by":"publisher","first-page":"6270","DOI":"10.1007\/s00330-022-08720-8","volume":"32","author":"SY Youn","year":"2022","unstructured":"Youn SY, Kim B, Kim DH, Choi HJ, Sung PS, Choi JI. Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma. European radiology. 2022;32:6270-80. https:\/\/doi.org\/10.1007\/s00330-022-08720-8","journal-title":"European radiology."},{"key":"4143_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000489790","volume":"8","author":"SC Chien","year":"2019","unstructured":"Chien SC, Chen CY, Cheng PN, Liu YS, Cheng HC, Chuang CH, Chang TT, Chiu HC, Lin YJ, Chiu YC. Combined Transarterial Embolization\/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study. Liver cancer. 2019;8:186-202. https:\/\/doi.org\/10.1159\/000489790","journal-title":"Liver cancer."},{"key":"4143_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md). 2018;68:723-50. https:\/\/doi.org\/10.1002\/hep.29913","journal-title":"Hepatology (Baltimore, Md)."},{"key":"4143_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","volume":"11","author":"M Omata","year":"2017","unstructured":"Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatology international. 2017;11:317-70. https:\/\/doi.org\/10.1007\/s12072-017-9799-9","journal-title":"Hepatology international."},{"key":"4143_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1148\/radiol.2018181494","volume":"289","author":"V Chernyak","year":"2018","unstructured":"Chernyak V, Fowler KJ, Kamaya A, Kielar AZ, Elsayes KM, Bashir MR, Kono Y, Do RK, Mitchell DG, Singal AG, Tang A, Sirlin CB. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radiology. 2018;289:816-30. https:\/\/doi.org\/10.1148\/radiol.2018181494","journal-title":"Radiology."},{"key":"4143_CR10","doi-asserted-by":"publisher","unstructured":"Rimola J, Davenport MS, Liu PS, Brown T, Marrero JA, McKenna BJ, Hussain HK. Diagnostic accuracy of MRI with extracellular vs. hepatobiliary contrast material for detection of residual hepatocellular carcinoma after locoregional treatment. Abdominal radiology (New York). 2019;44:549\u201358. https:\/\/doi.org\/10.1007\/s00261-018-1775-x","DOI":"10.1007\/s00261-018-1775-x"},{"key":"4143_CR11","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1007\/s00261-019-01968-7","volume":"44","author":"JH Yim","year":"2019","unstructured":"Yim JH, Kim YK, Min JH, Lee J, Kang TW, Lee SJ. Diagnosis of recurrent HCC: intraindividual comparison of gadoxetic acid MRI and extracellular contrast-enhanced MRI. Abdominal radiology (New York). 2019;44:2366-76. https:\/\/doi.org\/10.1007\/s00261-019-01968-7","journal-title":"Abdominal radiology (New York)."},{"key":"4143_CR12","doi-asserted-by":"publisher","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of internal medicine. 2009;151:W65-94. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00136","journal-title":"Annals of internal medicine."},{"key":"4143_CR13","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1111\/liv.13731","volume":"38","author":"MY Jeon","year":"2018","unstructured":"Jeon MY, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Baek SE, Kim HS, Kim SU, Park MS. Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib. Liver international : official journal of the International Association for the Study of the Liver. 2018;38:1655-63. https:\/\/doi.org\/10.1111\/liv.13731","journal-title":"Liver international : official journal of the International Association for the Study of the Liver."},{"key":"4143_CR14","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jhep.2017.12.014","volume":"68","author":"M Ronot","year":"2018","unstructured":"Ronot M, Fouque O, Esvan M, Lebigot J, Aub\u00e9 C, Vilgrain V. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3\u202fcm. Journal of hepatology. 2018;68:715-23. https:\/\/doi.org\/10.1016\/j.jhep.2017.12.014","journal-title":"Journal of hepatology."},{"key":"4143_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of internal medicine. 2011;155:529-36. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Annals of internal medicine."},{"key":"4143_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/sim.1040","volume":"21","author":"HC van Houwelingen","year":"2002","unstructured":"van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Statistics in medicine. 2002;21:589-624. https:\/\/doi.org\/10.1002\/sim.1040","journal-title":"Statistics in medicine."},{"key":"4143_CR17","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","volume":"58","author":"JJ Deeks","year":"2005","unstructured":"Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Journal of clinical epidemiology. 2005;58:882-93. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.01.016","journal-title":"Journal of clinical epidemiology."},{"key":"4143_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00261-007-9244-y","volume":"33","author":"N Bolog","year":"2008","unstructured":"Bolog N, Pfammatter T, M\u00fcllhaupt B, Andreisek G, Weishaupt D. Double-contrast magnetic resonance imaging of hepatocellular carcinoma after transarterial chemoembolization. Abdominal imaging. 2008;33:313-23. https:\/\/doi.org\/10.1007\/s00261-007-9244-y","journal-title":"Abdominal imaging."},{"key":"4143_CR19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/jmri.21316","volume":"27","author":"S Goshima","year":"2008","unstructured":"Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator? Journal of magnetic resonance imaging : JMRI. 2008;27:834-9. https:\/\/doi.org\/10.1002\/jmri.21316","journal-title":"Journal of magnetic resonance imaging : JMRI."},{"key":"4143_CR20","doi-asserted-by":"publisher","unstructured":"Jin W, Qing D, Yun-Jing X, Bin S. Dynamic contrast-enhanced VIBE sequence at 3.0T MR:assessment of therapeutic effect of transcatheter arterial chemoembolization for hepatocellucer carcinoma. Chinese Journal of Interventional Imaging and Therapy. 2008;5:115\u20138. https:\/\/doi.org\/10.1672\/chin.jIntervim.2008.02.015","DOI":"10.1672\/chin.jIntervim.2008.02.015"},{"key":"4143_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/jmri.21818","volume":"30","author":"JS Yu","year":"2009","unstructured":"Yu JS, Kim JH, Chung JJ, Kim KW. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas. Journal of magnetic resonance imaging : JMRI. 2009;30:153-60. https:\/\/doi.org\/10.1002\/jmri.21818","journal-title":"Journal of magnetic resonance imaging : JMRI."},{"key":"4143_CR22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jvir.2010.05.015","volume":"21","author":"B Kalb","year":"2010","unstructured":"Kalb B, Chamsuddin A, Nazzal L, Sharma P, Martin DR. Chemoembolization follow-up of hepatocellular carcinoma with MR imaging: usefulness of evaluating enhancement features on one-month posttherapy MR imaging for predicting residual disease. Journal of vascular and interventional radiology : JVIR. 2010;21:1396-404. https:\/\/doi.org\/10.1016\/j.jvir.2010.05.015","journal-title":"Journal of vascular and interventional radiology : JVIR."},{"key":"4143_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ejrnm.2013.09.012","volume":"44","author":"RM Osama","year":"2013","unstructured":"Osama RM, Abdelmaksoud AHK, El Tatawy SAM, Nabeel MM, Metwally LIA. Role of dynamic contrast-enhanced and diffusion weighted MRI in evaluation of necrosis of hepatocellular carcinoma after chemoembolization. Egyptian Journal of Radiology and Nuclear Medicine. 2013;44:737\u201346. https:\/\/doi.org\/10.1016\/j.ejrnm.2013.09.012","journal-title":"Egyptian Journal of Radiology and Nuclear Medicine."},{"key":"4143_CR24","doi-asserted-by":"publisher","unstructured":"Ebeed AE, Romeih EH, Refat MM, Yossef MH. Role of dynamic contrast-enhanced and diffusion weighted MRI in evaluation of hepatocellular carcinoma after chemoembolization. Egyptian Journal of Radiology and Nuclear Medicine. 2017;48. https:\/\/doi.org\/10.1016\/j.ejrnm.2017.06.006","DOI":"10.1016\/j.ejrnm.2017.06.006"},{"key":"4143_CR25","doi-asserted-by":"publisher","unstructured":"Saleh TY, Bahig S, Shebrya N, Ahmed AY. Value of dynamic and DWI MRI in evaluation of HCC viability after TACE via LI-RADS v2018 diagnostic algorithm. Egyptian Journal of Radiology and Nuclear Medicine. 2019;50. https:\/\/doi.org\/10.1186\/s43055-019-0120-x","DOI":"10.1186\/s43055-019-0120-x"},{"key":"4143_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1148\/radiol.2019191581","volume":"294","author":"M Chaudhry","year":"2020","unstructured":"Chaudhry M, McGinty KA, Mervak B, Lerebours R, Li C, Shropshire E, Ronald J, Commander L, Hertel J, Luo S, Bashir MR, Burke LMB. The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma. Radiology. 2020;294:320-6. https:\/\/doi.org\/10.1148\/radiol.2019191581","journal-title":"Radiology."},{"key":"4143_CR27","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.diii.2022.06.007","volume":"103","author":"AS Abdelrahman","year":"2022","unstructured":"Abdelrahman AS, Ekladious MEY, Badran EM, Madkour SS. Liver imaging reporting and data system (LI-RADS) v2018: Reliability and agreement for assessing hepatocellular carcinoma locoregional treatment response. Diagnostic and interventional imaging. 2022;103:524-34. https:\/\/doi.org\/10.1016\/j.diii.2022.06.007","journal-title":"Diagnostic and interventional imaging."},{"key":"4143_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2214\/ajr.11.6844","volume":"198","author":"H Watanabe","year":"2012","unstructured":"Watanabe H, Kanematsu M, Goshima S, Yoshida M, Kawada H, Kondo H, Moriyama N. Is gadoxetate disodium-enhanced MRI useful for detecting local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy? AJR American journal of roentgenology. 2012;198:589-95. https:\/\/doi.org\/10.2214\/ajr.11.6844","journal-title":"AJR American journal of roentgenology."},{"key":"4143_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s00330-019-06351-0","volume":"30","author":"J Rimola","year":"2020","unstructured":"Rimola J, Forner A, Sapena V, Llarch N, Darnell A, D\u00edaz A, Garc\u00eda-Criado A, Bianchi L, Vilana R, D\u00edaz-Gonz\u00e1lez \u00c1, Ayuso C, Bruix J, Reig M. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma. European radiology. 2020;30:186-94. https:\/\/doi.org\/10.1007\/s00330-019-06351-0","journal-title":"European radiology."},{"key":"4143_CR30","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.acra.2020.04.003","volume":"28","author":"HF Liu","year":"2021","unstructured":"Liu HF, Xu YS, Liu Z, Che KY, Sheng Y, Ding JL, Zhang JG, Lei JQ, Xing W. Value of Gd-EOB-DTPA-Enhanced MRI and Diffusion-Weighted Imaging in Detecting Residual Hepatocellular Carcinoma After Drug-Eluting Bead Transarterial Chemoembolization. Academic radiology. 2021;28:790-8. https:\/\/doi.org\/10.1016\/j.acra.2020.04.003","journal-title":"Academic radiology."},{"key":"4143_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.869993","volume":"13","author":"Q He","year":"2022","unstructured":"He Q, Yang J, Jin Y. Development and Validation of TACE Refractoriness-Related Diagnostic and Prognostic Scores and Characterization of Tumor Microenvironment Infiltration in Hepatocellular Carcinoma. Frontiers in immunology. 2022;13:869993. https:\/\/doi.org\/10.3389\/fimmu.2022.869993","journal-title":"Frontiers in immunology."},{"key":"4143_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100443","volume":"4","author":"D Nam","year":"2022","unstructured":"Nam D, Chapiro J, Paradis V, Seraphin TP, Kather JN. Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction. JHEP reports : innovation in hepatology. 2022;4:100443. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100443","journal-title":"JHEP reports : innovation in hepatology."},{"key":"4143_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000030875","volume":"101","author":"SW Lee","year":"2022","unstructured":"Lee SW, Yen CL, Cheng YC, Shun Yang S, Lee TY. The radiological prognostic factors of transcatheter arterial chemoembolization to hepatocellular carcinoma. Medicine. 2022;101:e30875. https:\/\/doi.org\/10.1097\/md.0000000000030875","journal-title":"Medicine."},{"key":"4143_CR34","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1148\/radiol.14131996","volume":"271","author":"MH Yu","year":"2014","unstructured":"Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW, Han JK, Choi BI. Small (\u22641-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging. Radiology. 2014;271:748-60. https:\/\/doi.org\/10.1148\/radiol.14131996","journal-title":"Radiology."},{"key":"4143_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000507370","volume":"9","author":"M Kudo","year":"2020","unstructured":"Kudo M, Han KH, Ye SL, Zhou J, Huang YH, Lin SM, Wang CK, Ikeda M, Chan SL, Choo SP, Miyayama S, Cheng AL. A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements. Liver cancer. 2020;9:245-60. https:\/\/doi.org\/10.1159\/000507370","journal-title":"Liver cancer."},{"key":"4143_CR36","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/jmri.26540","volume":"49","author":"V Chernyak","year":"2019","unstructured":"Chernyak V, Fowler KJ, Heiken JP, Sirlin CB. Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI-RADS). Journal of magnetic resonance imaging : JMRI. 2019;49:1236-52. https:\/\/doi.org\/10.1002\/jmri.26540","journal-title":"Journal of magnetic resonance imaging : JMRI."},{"key":"4143_CR37","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1007\/s00261-018-1462-y","volume":"43","author":"W Zhang","year":"2018","unstructured":"Zhang W, Wang X, Miao Y, Hu C, Zhao W. Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla. Abdominal radiology (New York). 2018;43:2262-9. https:\/\/doi.org\/10.1007\/s00261-018-1462-y","journal-title":"Abdominal radiology (New York)."},{"key":"4143_CR38","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.cgh.2019.12.010","volume":"18","author":"JH Min","year":"2020","unstructured":"Min JH, Kim JM, Kim YK, Cha DI, Kang TW, Kim H, Choi GS, Choi SY, Ahn S. Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2020;18:2091-100.e7. https:\/\/doi.org\/10.1016\/j.cgh.2019.12.010","journal-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association."},{"key":"4143_CR39","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/jmri.21689","volume":"29","author":"T Tamada","year":"2009","unstructured":"Tamada T, Ito K, Sone T, Yamamoto A, Yoshida K, Kakuba K, Tanimoto D, Higashi H, Yamashita T. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. Journal of magnetic resonance imaging : JMRI. 2009;29:636-40. https:\/\/doi.org\/10.1002\/jmri.21689","journal-title":"Journal of magnetic resonance imaging : JMRI."},{"key":"4143_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1148\/radiol.2015150642","volume":"279","author":"U Motosugi","year":"2016","unstructured":"Motosugi U, Bannas P, Bookwalter CA, Sano K, Reeder SB. An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging. Radiology. 2016;279:93-102. https:\/\/doi.org\/10.1148\/radiol.2015150642","journal-title":"Radiology."},{"key":"4143_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1148\/radiol.10091885","volume":"256","author":"U Motosugi","year":"2010","unstructured":"Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Radiology. 2010;256:151-8. https:\/\/doi.org\/10.1148\/radiol.10091885","journal-title":"Radiology."},{"key":"4143_CR42","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.2019190010","volume":"1","author":"RL Brunsing","year":"2019","unstructured":"Brunsing RL, Chen DH, Schlein A, Wolfson T, Gamst A, Mamidipalli A, Vietti Violi N, Marks RM, Taouli B, Loomba R, Kono Y, Sirlin CB. Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience. Radiology Imaging cancer. 2019;1:e190010. https:\/\/doi.org\/10.1148\/rycan.2019190010","journal-title":"Radiology Imaging cancer."},{"key":"4143_CR43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2214\/ajr.14.12986","volume":"204","author":"RM Marks","year":"2015","unstructured":"Marks RM, Ryan A, Heba ER, Tang A, Wolfson TJ, Gamst AC, Sirlin CB, Bashir MR. Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. AJR American journal of roentgenology. 2015;204:527-35. https:\/\/doi.org\/10.2214\/ajr.14.12986","journal-title":"AJR American journal of roentgenology."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-04143-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-023-04143-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-04143-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T07:05:53Z","timestamp":1706684753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-023-04143-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["4143"],"URL":"https:\/\/doi.org\/10.1007\/s00261-023-04143-1","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was not required for this study because this is a systematic review. Institutional Review Board approval was not required because this is a systematic review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}